Skip to main content

PDL search tool and updates

Stay up to date with your medicine. A preferred drug list (PDL) is a list of medicines we cover. It can help you manage your medicines. 

Questions?

Call us at 1-844-365-4385 (TTY: 711). We’re here for you 24 hours a day, 7 days a week. 

Your PDL search tool

There are many different things that you can do with your PDL search tool. You can:

 

  • Search for your medicine by name or class

  • Find generic alternatives to your medicine

  • See if your medicine has quantity limits, has age limits or needs prior authorization

 

  • March 2025

     

    Additions:

    • None

     

    Removals:

    • None

     

    Other Updates:

    • None

     

    February 2025

     

    Additions:

    • None

     

    Removals:

    • None

     

    Other Updates:

    • Flovent Diskus 100 mcg per act inhaler (Updated to Tier 2 with Prior Authorization)
    • Flovent Diskus 250 mcg per act inhaler (Updated to Tier 2 with Prior Authorization)
    • Flovent Diskus 50 mcg per act inhaler (Updated to Tier 2 with Prior Authorization)
    • Flovent HFA 110 mcg per act inhaler (Updated to Tier 2 with Prior Authorization)
    • Flovent HFA 220 mcg per act inhaler (Updated to Tier 2 with Prior Authorization)
    • Flovent HFA 44 mcg per act inhaler (Updated to Tier 2 with Prior Authorization)
    • Fluticasone propionate diskus 100 mcg per act inhaler (Updated to Tier 2 with Prior Authorization)
    • Fluticasone propionate diskus 250 mcg per act inhaler (Updated to Tier 2 with Prior Authorization)
    • Fluticasone propionate diskus 50 mcg per act inhaler (Updated to Tier 2 with Prior Authorization)
    • Fluticasone propionate HFA 110 mcg per act inhaler (Updated to Tier 2 with Prior Authorization)
    • Fluticasone propionate HFA 220 mcg per act inhaler (Updated to Tier 2 with Prior Authorization)
    • Fluticasone propionate HFA 44 mcg per act inhaler (Updated to Tier 2 with Prior Authorization)
    • Qvar RediHaler 40 mcg per act inhaler (Updated to Tier 1)
    • Qvar RediHaler 80 mcg per act inhaler (Updated to Tier 1)
    • Wixela 100 mcg / 50 mcg per act inhaler (Removed Prior Authorization)
    • Wixela 250 mcg / 50 mcg per act inhaler (Removed Prior Authorization)
    • Wixela 500 mcg / 50 mcg per act inhaler (Removed Prior Authorization)

     

    January 2025

     

    Additions:
    • None

     

    Removals:
    • None

     

    Other Updates:
    • None
  • December 2024

     

    Additions:
    • None

     

    Removals:
    • None

     

    Other Updates:
    • None

     

    November 2024

     

    Additions:
    • None

     

    Removals:
    • None

     

    Other Updates:
    • None

     

    October 2024

     

    Additions:
    • None

     

    Removals:
    • None

     

    Other Updates:
    • None

     

    September 2024

     

    Additions:
    • None

     

    Removals:
    • Oxbryta 300 mg soluble tablet
    • Oxbryta 300 mg tablet
    • Oxbryta 500 mg tablet

     

    Other Updates:
    • Alclometasone 0.05% ointment (Updated to Tier 2)
    • Calcipotriene 0.005% / betamethasone dipropionae 0.064% ointment (Updated to Tier 3)
    • Calcipotriene 0.005% / betamethasone dipropionae 0.064% suspension (Updated to Tier 3)
    • Clindacin ETZ 1% cleanser kit (Updated to Special PA)
    • Clobetasol 0.05% spray (Updated to Tier 2)
    • Clocortolone 0.1% cream (Updated to Tier 3)
    • Cloderm 0.1% cream (Updated to Tier 3)
    • Halcinonide 0.1% cream (Updated to Tier 3)
    • Halog 0.1% cream (Updated to Tier 3)
    • Halog 0.1% ointment (Updated to Tier 3)
    • Halog 0.1% solution (Updated to Tier 3)
    • Hydrocodone 10 mg / acetaminophen 300 mg tablet (Updated to Special PA)
    • Hydrocodone 5 mg / acetaminophen 300 mg tablet (Updated to Special PA)
    • Hydrocodone 7.5 mg / acetaminophen 300 mg tablet (Updated to Special PA)
    • Hydrocodone 7.5 mg / acetaminophen 325 mg per 15 mL solution (Updated to Special PA)
    • Hydrocortisone 0.1% lotion (Updated to Tier 3)
    • Hydrocortisone butyrate 0.1% cream (Updated to Tier 3)
    • Hydrocortisone valerate 0.2% cream (Updated to Tier 1)
    • Locoid 0.1% lotion (Updated to Tier 3)
    • Methadone 10 mg per 5 mL solution (Updated to Special PA)
    • Methadone 5 mg per 5 mL solution (Updated to Special PA)
    • Nalocet 2.5 mg/300 mg tablet (Updated to Special PA)
    • Prolate 10 mg / 300 mg per 5 mL solution (Updated to Special PA)
    • Prolate 10 mg / 300 mg tablet (Updated to Special PA)
    • Prolate 5 mg / 300 mg tablet (Updated to Special PA)
    • Prolate 7.5 mg / 300 mg tablet (Updated to Special PA)
    • Taclonex 0.005% / 0.064% ointment (Updated to Tier 3)
    • Taclonex 0.005% / 0.064% suspension (Updated to Tier 3)

     

    August 2024

     

    Additions:

     

    • None

     

    Removals:

     

    • None

     

    Other Updates:

     

    • None

     

    July 2024

     

    Additions:

     

    • None

     

    Removals:

     

    • None

     

    Other Updates:

     

    • Aveed 750 gm per 3 mL intramuscular injection (Updated to Special PA)
    • Baclofen 5 mg tablet (Updated to Special PA)
    • Bismuth 140 mg /metronidazole 125 mg/ tetracycline 125 mg capsule (Removed Brand Preferred, Updated to Special PA)
    • Combogesic 1000 mg/300 mg per 100 mL intravenous solution (Updated to Special PA)
    • Elyxyb 120 mg per 4.8 mL oral solution (Updated to Special PA)
    • Farxiga 10 mg tablet (Added to Brand Preferred)
    • Farxiga 5 mg tablet (Added to Brand Preferred)
    • Insulin glargine-yfgn 100 unit per mL injection (Removed Prior Authorization)
    • Insulin glargine-yfgn 100 unit per mL pen-injector solution (Removed Prior Authorization)
    • Invokamet 150/1000 mg tablet (Updated to Tier 2)
    • Invokamet 150/500 mg tablet (Updated to Tier 2)
    • Invokamet 50/1000 mg tablet (Updated to Tier 2)
    • Invokamet 50/500 mg tablet (Updated to Tier 2)
    • Invokamet XR 150/1000 mg tablet (Updated to Tier 2)
    • Invokamet XR 150/500 mg tablet (Updated to Tier 2)
    • Invokamet XR 50/1000 mg tablet (Updated to Tier 2)
    • Invokamet XR 50/500 mg tablet (Updated to Tier 2)
    • Invokana 100 mg tablet (Updated to Tier 2)
    • Invokana 300 mg tablet (Updated to Tier 2)
    • Kombiglyze XR 2.5/1000 mg tablet (Updated to Special PA)
    • Kombiglyze XR 5/1000 mg tablet (Updated to Special PA)
    • Kombiglyze XR 5/500 mg tablet (Updated to Special PA)
    • Natesto 5.5 mg per actuation nasal gel (Updated to Special PA)
    • Neo-synalar 0.5/0.025% cream (Updated to Tier 2)
    • Olopatadine 0.6 % nasal spray (Updated to Tier 2)
    • Omnaris 50 mcg nasal spray (Updated to Tier 1)
    • Onglyza 2.5 mg tablet (Updated to Special PA)
    • Onglyza 5 mg tablet (Updated to Special PA)
    • Saxagliptin 2.5 mg tablet (Updated to Special PA)
    • Saxagliptin 2.5 mg/ metformin 1000 mg ER tablet (Updated to Special PA)
    • Saxagliptin 5 mg tablet (Updated to Special PA)
    • Saxagliptin 5 mg/ metformin 1000 mg ER tablet (Updated to Special PA)
    • Saxagliptin 5 mg/ metformin 500 mg ER tablet (Updated to Special PA)
    • Xigduo XR 10/1000 mg tablet (Added to Brand Preferred)
    • Xigduo XR 10/500 mg tablet (Added to Brand Preferred)
    • Xigduo XR 2.5/1000 mg tablet (Added to Brand Preferred)
    • Xigduo XR 5/1000 mg tablet (Added to Brand Preferred)
    • Xigduo XR 5/500 mg tablet (Added to Brand Preferred)
    • Zetonna 37 mcg nasal solution (Updated to Tier 1)

     

    June 2024

     

    Additions:

     

    • None

     

    Removals:

     

    • None

     

    Other Updates:

     

    • Amoxicillin 500 mg capsule/clarithromycin 500 mg tablet/lansoprazole 30 mg capsule (Updated to Special PA)
    • Bismuth 140 mg/metronidazole 125 mg/tetracycline 125 mg capsule (Updated to Special PA)
    • Dapagliflozin 10 mg tablet (Updated to Special PA)
    • Dapagliflozin 10mg/metformin 1000 mg ER tablet (Updated to Special PA)
    • Dapagliflozin 5 mg tablet (Updated to Special PA)
    • Dapagliflozin 5mg/metformin 1000 mg ER tablet (Updated to Special PA)
    • Farxiga 10 mg tablet (Added to Brand Preferred)
    • Farxiga 5 mg tablet (Added to Brand Preferred)
    • Glipizide 2.5 mg tablet (Updated to Special PA)
    • Inpefa 200 mg tablet (Updated to Special PA)
    • Inpefa 400 mg tablet (Updated to Special PA)
    • Invokamet 150/1000 mg tablet (Updated to Tier 2)
    • Invokamet 150/500 mg tablet (Updated to Tier 2, Added Step Therapy)
    • Invokamet 50/1000 mg tablet (Updated to Tier 2, Added Step Therapy)
    • Invokamet 50/500 mg tablet (Updated to Tier 2, Added Step Therapy)
    • Invokamet XR 150/1000 mg tablet (Updated to Tier 2, Added Step Therapy)
    • Invokamet XR 150/500 mg tablet (Updated to Tier 2, Added Step Therapy)
    • Invokamet XR 50/1000 mg tablet (Updated to Tier 2, Added Step Therapy)
    • Invokamet XR 50/500 mg tablet (Updated to Tier 2, Added Step Therapy)
    • Invokana 100 mg tablet (Updated to Tier 2, Added Step Therapy)
    • Invokana 300 mg tablet (Updated to Tier 2, Added Step Therapy)
    • Kombiglyze XR 2.5/1000 mg tablet (Updated to Special PA, Removed Step Therapy))
    • Kombiglyze XR 5/1000 mg tablet (Updated to Special PA, Removed Step Therapy))
    • Kombiglyze XR 5/500 mg tablet (Updated to Special PA, Removed Step Therapy))
    • Ngenla 24 mg per 1.2 mL injection (Updated to Tier 2)
    • Ngenla 60 mg per 1.2 mL injection (Updated to Tier 2)
    • Onglyza 2.5 mg tablet (Updated to Special PA, Removed Step Therapy)
    • Onglyza 5 mg tablet (Updated to Special PA, Removed Step Therapy)
    • Pylera capsule (Updated to Special PA, Removed from Brand Preferred)
    • Saxagliptin 2.5 mg tablet (Updated to Special PA)
    • Saxagliptin 2.5 mg/metformin 1000 mg tablet (Updated to Special PA)
    • Voquenza 10 mg tablet (Updated to Special PA)
    • Voquenza 20 mg tablet (Updated to Special PA)
    • Voquenza dual pak (Updated to Special PA)
    • Voquenza triple pak (Updated to Special PA)
    • Xigduo XR 10/1000 mg tablet (Added to Brand Preferred)
    • Xigduo XR 10/500 mg tablet (Added to Brand Preferred)
    • Xigduo XR 2.5/1000 mg tablet (Added to Brand Preferred)
    • Xigduo XR 5/1000 mg tablet (Added to Brand Preferred)
    • Xigduo XR 5/500 mg tablet (Added to Brand Preferred)
    • Zituvio 100 mg tablet (Updated to Special PA)
    • Zituvio 25 mg tablet (Updated to Special PA)
    • Zituvio 50 mg tablet (Updated to Special PA)

     

    May 2024

     

    Additions:

     

    • None

     

    Removals:

     

    • None

     

    Other Updates:

     

    • Aptensio XR 10 mg capsule (Removed from Brand preferred)
    • Aptensio XR 15 mg capsule (Removed from Brand preferred)
    • Aptensio XR 20 mg capsule (Removed from Brand preferred)
    • Aptensio XR 30 mg capsule (Removed from Brand preferred)
    • Aptensio XR 40 mg capsule (Removed from Brand preferred)
    • Aptensio XR 50 mg capsule (Removed from Brand preferred)
    • Aptensio XR 60 mg capsule (Removed from Brand preferred)
    • Dynavel XR 2.5 mg per mL suspension (Updated to Tier 3)
    • Nuvigil 150mg tablet (Removed from Brand preferred)
    • Nuvigil 200mg tablet (Removed from Brand preferred)
    • Nuvigil 250mg tablet (Removed from Brand preferred)
    • Nuvigil 50mg tablet (Removed from Brand preferred)

     

    April 2024

     

    Additions

     

    • To come

    Removals

     

    • To come

    Other updates

     

    • To come

Also of interest: